For the year ending 2026-01-03, HNI had $195,400K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-01-03 |
|---|---|
| Net income | 54,200 |
| Depreciation and amortization | 107,100 |
| Other post-retirement and post-employment benefits | 1,900 |
| Stock-based compensation | 24,700 |
| Deferred income taxes | 33,700 |
| Asset impairment charges | 7,700 |
| Loss on sale of subsidiary | -6,600 |
| Other net | -14,300 |
| Net increase (decrease) in cash from operating assets and liabilities | -23,900 |
| Decrease in other liabilities | 2,100 |
| Net cash flows from (to) operating activities | 276,300 |
| Capital expenditures | 65,800 |
| Acquisition spending, net of cash acquired | 390,300 |
| Capitalized software | 2,000 |
| Purchase of investments | 2,800 |
| Sales or maturities of investments | 4,800 |
| Net proceeds from sale of subsidiary | 8,100 |
| Other net | -4,100 |
| Net cash flows from (to) investing activities | -443,900 |
| Payments of debt | 782,500 |
| Proceeds from debt | 1,296,700 |
| Dividends paid | 63,100 |
| Purchase of hni corporation common stock | 83,600 |
| Proceeds from sales of hni corporation common stock | 3,800 |
| Debt-issuance costs | 14,600 |
| Withholding related to net share settlements of equity based awards | 13,300 |
| Proceeds from coli | 32,000 |
| Other net | -12,500 |
| Net cash flows from (to) financing activities | 363,100 |
| Net increase (decrease) in cash and cash equivalents | 195,400 |
| Cash, cash equivalents, and restricted cash at beginning of period | 22,500 |
| Cash, cash equivalents, and restricted cash at end of period | 217,900 |
HNI CORP (HNI)
HNI CORP (HNI)